Research ArticleArticle
High-Activity P-Glycoprotein, Multidrug Resistance Protein 2, and Breast Cancer Resistance Protein Membrane Vesicles Prepared from Transiently Transfected Human Embryonic Kidney 293-Epstein-Barr Virus Nuclear Antigen Cells
Johan E. Karlsson, Catherine Heddle, Aleksei Rozkov, Joke Rotticci-Mulder, Ola Tuvesson, Constanze Hilgendorf and Tommy B. Andersson
Drug Metabolism and Disposition April 2010, 38 (4) 705-714; DOI: https://doi.org/10.1124/dmd.109.028886
Johan E. Karlsson
Catherine Heddle
Aleksei Rozkov
Joke Rotticci-Mulder
Ola Tuvesson
Constanze Hilgendorf
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
High-Activity P-Glycoprotein, Multidrug Resistance Protein 2, and Breast Cancer Resistance Protein Membrane Vesicles Prepared from Transiently Transfected Human Embryonic Kidney 293-Epstein-Barr Virus Nuclear Antigen Cells
Johan E. Karlsson, Catherine Heddle, Aleksei Rozkov, Joke Rotticci-Mulder, Ola Tuvesson, Constanze Hilgendorf and Tommy B. Andersson
Drug Metabolism and Disposition April 1, 2010, 38 (4) 705-714; DOI: https://doi.org/10.1124/dmd.109.028886
Research ArticleArticle
High-Activity P-Glycoprotein, Multidrug Resistance Protein 2, and Breast Cancer Resistance Protein Membrane Vesicles Prepared from Transiently Transfected Human Embryonic Kidney 293-Epstein-Barr Virus Nuclear Antigen Cells
Johan E. Karlsson, Catherine Heddle, Aleksei Rozkov, Joke Rotticci-Mulder, Ola Tuvesson, Constanze Hilgendorf and Tommy B. Andersson
Drug Metabolism and Disposition April 1, 2010, 38 (4) 705-714; DOI: https://doi.org/10.1124/dmd.109.028886
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement